ITOC2 – 019. An open-label multicenter phase II trial of aviscumine in previously treated patients with unresectable stage IV metastatic melanoma
Uwe, Trefzer, Ralf, Gutzmer, Tabea, Wilhelm, Florian, Schenck, Katharina C., Kähler, Volkmar, Jacobi, Klaus, Witthohn, Hans, Lentzen, Peter, MohrVolume:
51
Language:
english
Journal:
European Journal of Cancer
DOI:
10.1016/j.ejca.2015.01.032
Date:
March, 2015
File:
PDF, 37 KB
english, 2015